Phase I/II trial of thioureidobutyronitrile (Kevetrin)+ cytarabine in patients with acute myeloid leukaemia

Trial Profile

Phase I/II trial of thioureidobutyronitrile (Kevetrin)+ cytarabine in patients with acute myeloid leukaemia

Planning
Phase of Trial: Phase I/II

Latest Information Update: 24 Sep 2014

At a glance

  • Drugs Thioureidobutyronitrile (Primary) ; Cytarabine
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Sponsors Innovation Pharmaceuticals
  • Most Recent Events

    • 24 Sep 2014 The protocol for this trial has been submitted to the ethics committee, according to a Cellceutix media release. This trial is expected to start in quarter 4, 2014.
    • 09 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top